Dupont to invest $28Mn to produce advanced chip materials in S.Korea

By Nikita Chaurasia  Date: 2020-01-11

Dupont to invest $28Mn to produce advanced chip materials in S.Korea

The company plans to develop a new facility in South Korea that would help reduce its dependency on Japan for semiconductor products.

As Japan’s diplomatic relations with South Korea sour up, U.S. chemical company DuPont has revealed plans to invest $28 million in South Korea to develop advanced photoresists along with other components by the year 2021. This investment would benefit South Korea by lowering its dependence on Japan for components used in semiconductor manufacturing.

The latest trade restriction from Japan has compelled tech companies in South Korea to diversify their supply chain. Although, Japan withdrew limitation on the export of photoresists, it has toughened its restriction on two components, namely hydrogen fluoride and fluorinated polyimides. Apparently, hydrogen fluoride acts as an etching gas which is used while making processors whereas fluorinated polyimides are required in the displays of smartphones.    

Speaking on the investment, Sung Yoon-mo, Industry Minister, South Korea, said that even if the Japanese authorities have eased the restriction on photoresists now, which for time-being can be seen as partial progress, it cannot be considered as a fundamental solution.

Meanwhile, a trade ministry official claims that DuPont plans to invest in two existing factories in South Korea and aims on developing a new production facility as well. Adding further, the official said that Dupont's Korean subsidiary currently develops photoresists, however, didn’t require to make chips with advanced technique like EUV lithography or extreme ultraviolet.

As per reliable reports, Japan is said to produce around 90% of photoresists. These components are basically thin layers of material used to transfer circuit patterns on semiconductor wafers. Reports also suggest that the latest investment would advance the production of CMP pads. These pads are usually used during the semiconductor manufacturing process as polishing pads.

Source Credit: https://www.nasdaq.com/articles/amid-trade-row-with-japan-s.korea-gains-dupont-investment-to-make-chip-materials-2020-01

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

France might ban short domestic flights to reduce its carbon footprint

France might ban short domestic flights to reduce its carbon footprint

By Nikita Chaurasia

French lawmakers recently came to a unanimous decision to ban domestic flights for distances that can be covered by train in over two-and-a-half- hours. The country aims to impose these restrictions in an effort to reduce carbon emissions, even as th...

Kavak secures USD 485 million in funding, eyes Latin America expansion

Kavak secures USD 485 million in funding, eyes Latin America expansion

By Nikita Chaurasia

Kavak, a Mexico-based used-car platform, has reportedly reached a valuation of USD 4 billion after securing USD 485 million during a new funding round. This makes it the fastest-growing as well as the most valued company in Latin America. The latest...

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

Zydus seeks DCGI approval for PegIFN drug to treat COVID-19 patients

By Nikita Chaurasia

Indian pharmaceutical company Zydus Cadila is reportedly seeking approval from DCGI (Drug Controller General of India) for its PegIFN (Pegylated Interferon Alpha-2b), a hepatitis C drug, to treat COVID-19 patients, after its third phase of clinical t...

LinkedIn confirms launch of a social audio platform to rival Clubhouse

LinkedIn confirms launch of a social audio platform to rival Clubhouse

By Nikita Chaurasia

LinkedIn, the popular employment-oriented online service, has confirmed that it is testing a social audio experience in its app which could offer users with better connectivity in their networks. Although several social media giants such as Twitter ...

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

Pfizer begins Phase-1 trials of oral COVID-19 antiviral drug in U.S.

By Nikita Chaurasia

Pfizer Inc., an American multinational pharmaceutical corporation, has recently announced to have started the early phase trials for its oral antiviral drug for Coronavirus. The company revealed that first phase trials of the experimental drug, PF-07...